Keraflox Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Keraflox General Information

Description

A drug brand. The brand makes an oral antibiotic containing the active pharmaceutical ingredient Prulifloxacin which is used for the treatment of urinary tract infections and chronic bronchitis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
STADA Arzneimittel
Primary Office
  • Milan
  • Italy
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Keraflox Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Keraflox‘s full profile, request access.

Request a free trial

Keraflox Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Keraflox‘s full profile, request access.

Request a free trial